Case Report
Accepted on 03 Oct 2025
Different therapeutic responses to osimertinib as first-line treatment for cavitated and non-cavitated squamous cell lung cancer with rare EGFR exon 19 deletion: Two case reports and a literature review
in Thoracic Oncology
- 631 views